Epify

Epify is a company focused on the development of epigenetic biomarkers aimed at improving the diagnosis and treatment of cancer. Founded through a collaboration between Maastricht University and the bioinformatics group of Ghent University, Epify leverages scientific expertise in epigenetics to create industrial applications that enhance the utility of these biomarkers. These biomarkers play a crucial role in regulating gene activity and are associated with various cancers, influencing disease progression. By ensuring that these advanced tools are accessible to patients and clinicians, Epify aims to facilitate earlier detection, accurate diagnosis, and personalized treatment options in oncology.